TLR stimulation of prostate tumor cells induces chemokine-mediated recruitment of specific immune cell types.
about
Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growthGenetic and epigenetic aspects of initiation and progression of hepatocellular carcinomaMucins and toll-like receptors: kith and kin in infection and cancerThe same and not the same: heterogeneous functional activation of prostate tumor cells by TLR ligationToll-like receptor, RIG-I-like receptors and the NLRP3 inflammasome: key modulators of innate immune responses to double-stranded RNA viruses.Influence of the CXCL1 rs4074 A allele on alcohol induced cirrhosis and HCC in patients of European descent.TLR3 engagement induces IRF-3-dependent apoptosis in androgen-sensitive prostate cancer cells and inhibits tumour growth in vivo.TLR5 Ligand-Secreting T Cells Reshape the Tumor Microenvironment and Enhance Antitumor Activity.Decreased expression of Toll-like receptor 4 and 5 during progression of prostate transformation in transgenic adenocarcinoma of mouse prostate mice.Targeting polyIC to EGFR over-expressing cells using a dsRNA binding protein domain tethered to EGF.Effects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and CancerToll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression.Toll-like receptors in prostate infection and cancer between bench and bedsideAndrogen-induced lncRNA POTEF-AS1 regulates apoptosis-related pathway to facilitate cell survival in prostate cancer cells.Stimulating natural killer cells to protect against cancer: recent developments.Toll-like receptors and prostate cancer.An iron oxide nanocarrier for dsRNA to target lymph nodes and strongly activate cells of the immune system.TLR7 expression is decreased during tumour progression in transgenic adenocarcinoma of mouse prostate mice and its activation inhibits growth of prostate cancer cells.Direct effect of dsRNA mimetics on cancer cells induces endogenous IFN-β production capable of improving dendritic cell function.Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells.Mechanisms regulating immune surveillance of cellular stress in cancer.Oncolytic virus-initiated protective immunity against prostate cancerTLR2∆22 (-196-174) significantly increases the risk of breast cancer in females carrying proline allele at codon 72 of TP53 gene: a case-control study from four ethnic groups of North Eastern region of India.A new role for microRNAs, as ligands of Toll-like receptors.Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy.PSMA-homing dsRNA chimeric protein vector kills prostate cancer cells and activates anti-tumor bystander responsesTLR4 promotes the expression of HIF-1α by triggering reactive oxygen species in cervical cancer cells in vitro-implications for therapeutic intervention.Pro-apoptotic signaling induced by Retinoic acid and dsRNA is under the control of Interferon Regulatory Factor-3 in breast cancer cells.TREM-1, an inflammatory modulator, is expressed in hepatocellular carcinoma cells and significantly promotes tumor progression.
P2860
Q24620395-71C21692-F656-4E59-85E2-955939A764CDQ26784412-9BF1E0BC-828B-4FAB-9C5E-10CAB988EE94Q26830597-4B1FC382-7DF4-4F3B-BEBF-52C9CE202508Q33801246-11DB2DFD-8B9A-453D-BC42-BB53B2A309E5Q35028032-E7D3BC1B-C5C4-48A2-81A4-FB2D14B20106Q35049299-FAEEEE6B-019A-42A5-AF26-FA538ACED868Q35531400-C29A5CAC-BB79-48F3-87BA-9AAD676FCF1EQ35612358-A67F114E-722C-49FE-9F38-8B949ADB7D2CQ36105484-B8019C5C-DB32-4F1A-8D6E-27DF1FF486ACQ36123983-B02A9258-E345-47ED-ACA8-003EA9EFC5E7Q36127825-92A9070E-8083-4E2D-842B-F92032F16E6FQ36932335-6AB75FD8-46F7-4CB2-87AE-80CDE7E928CAQ37295411-C1105896-24B9-4B72-81B0-0D71B8378E04Q37735619-91774E4E-F616-45D4-9351-A82655FBDBBBQ37877269-3346D495-B8A5-4363-85CA-99DA2AEAD2F5Q38237640-6BDC1D80-2732-4BF8-B571-BF42CE7509FDQ38966014-E0F05E32-0DF8-4549-B66A-44A2DCB26A69Q39136868-A117EE3C-2248-421C-8856-FF1F215B0B27Q39157595-A8F3B6FA-AB75-444D-BDB2-98426542B834Q39450716-CB33DEA3-9171-4503-8D33-03027EB4454BQ39458697-0B4CE4D4-BE8E-4F96-8101-062640D1B2B5Q39606073-3E3C106A-794D-4B84-8394-478D37AD312FQ40721174-DC6C641D-A9A6-4E8C-8E2B-404DD91C9807Q41295458-FEE30814-EDEC-49D2-B53C-98A3A7FE3AADQ41992352-E5DD7768-AE92-4D8D-BA79-FA85DA67D821Q42114642-53D15D4C-8374-4F42-8844-10DC3F46535BQ46247691-5BF9ECCE-DB2A-4F40-8E67-0C4386860BC3Q48275146-50029FD2-BABE-4E10-99F7-F37BE1FE9456Q52997142-8200373C-05AB-4861-9888-DE290CF823FD
P2860
TLR stimulation of prostate tumor cells induces chemokine-mediated recruitment of specific immune cell types.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
TLR stimulation of prostate tu ...... of specific immune cell types.
@en
TLR stimulation of prostate tu ...... of specific immune cell types.
@nl
type
label
TLR stimulation of prostate tu ...... of specific immune cell types.
@en
TLR stimulation of prostate tu ...... of specific immune cell types.
@nl
prefLabel
TLR stimulation of prostate tu ...... of specific immune cell types.
@en
TLR stimulation of prostate tu ...... of specific immune cell types.
@nl
P2093
P50
P356
P1476
TLR stimulation of prostate tu ...... of specific immune cell types
@en
P2093
Anna Riccioli
Antonio Filippini
Donatella Starace
Luca Battistini
Roberta Busà
Roberta Galli
P304
P356
10.4049/JIMMUNOL.0902401
P407
P577
2010-05-17T00:00:00Z